Activating mutations of the TSH receptor gene cause thyroid diseases

Annales d'Endocrinologie

Volumn 57, Issue 1, 1996, Pages 50-54

  Vassart, G ^a,b,c   Van Sande, J ^a   Parma, J ^a,b   Tonacchera, M ^a   Duprez, L ^a   Swillens, S ^a   Dumont, J ^a  

^a Inst de Rech Interdisciplinaire   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

activating mutations; TSH receptor

Indexed keywords

THYROTROPIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; HUMAN; MUTATION; THYROID DISEASE;

GENE EXPRESSION REGULATION; GENES; GERM-LINE MUTATION; HUMANS; HYPERTHYROIDISM; MUTATION; RECEPTORS, THYROTROPIN; STRUCTURE-ACTIVITY RELATIONSHIP; THYROID NEOPLASMS;

EID: 0029943645     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. COSTA T, OGINO Y, MUNSON PJ, ONARAN HU, RODBARD D. Drug efficacy at the guanine nucleotide-binding regulatory protein-linked receptors : thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol 1992 ; 41 : 549-60.
2. DUMONT JE, JAUNIAUX JC, ROGER PP. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 1989 ; 14 : 67-71.
3. DUMONT JE, LAMY F, ROGER P, MAENHALT C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiological Rev 1992 ; 72 : 667-97.
4. DUMONT JE, VASSART G, REFETOFF S Thyroid Disorders. In : Scriver C.R. Bal. ed. The Metabolic Basis of Inherited Diseases. McGraw-Hill. USA, 1989 : 1843-79
5. DUPREZ L, PARMA J, VAN SANDE J et al. Germline mutations in the thyrotropin receptor gene cause non autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994 : 7 : 396-401.
6. JI I, JI T. Human choriogonadotrophin binds to a lutropin receptor with essentially no N-terminal extension and stimulates cAMP synthesis. J Biol Chem 1991 , 266 : 1306-9.
7. KJELSBERG MA, COTECCHIA S, OSTROWSKI J, CARON MG, LEFKOWITZ RJ. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 1992 ; 267 : 1430-3.
8. KOPP P, Van SANDE J, PARMA J et al. Congenital non-autoimmune hyperthyroidism caused by a neomutation in the thyrotropin receptor gene. New Engl J Med 1995 ; 332 : 150-4.
9. KOSUGI S, OKAJIMA F., BAN T et al. Substitutions of different regions of the third cytoplasmic loop of the TSH receptor have selective effects on constitutive, TSH-and TSH receptor autoantibody-stimulated phosphinositide and cAMP signal generation. Mol Endocrinol 1994 ; 7 : 1009-20.
10. KREMER H, MARIMAN E, OTTEN BJ et al. Consegregation of missense mutations of the luteinizing hormone receptor gene withn familial male-limited precocious puberty. Hum Mol Genet 1993 : 2 : 1779-83.
11. LAURENT E, MOCKEL J, VAN SANDE J, GRAFF I, DUMONT JE. Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol 1987 ; 52 : 273-8.
12. LECLERE J, BÉNE MC, DUPREZ A et al. Behavior of thyroid tissue from patients with Graves'disease in nude mice. J Clin Endocrinol Metab 1984 ; 59 : 175-7.
13. LEFKOWITZ RJ, COTECCHIA S, SAMAMA P, COSTA T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. TiPS 1994 ; 14 : 303-7.
14. NAGAYAMA Y, RAPAPPORT B: The thyrotropin receptor 25 years after its discovery : new insight after its molecular cloning. Mol Endocrinol 1992 ; 6 : 145-56.
15. O'SULLIVAN C, BARTON CM, STADDON SL, BROWN CL, LEMOINE NR. Activating point mutations of the gsp oncogen in human thyroid adenomas. Mol Carcinog 1991 ; 4 : 345-9.
16. PARMA J, DUPREZ L, VAN SANDE J et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993 , 365 : 649-51.
17. PARMA J, VAN SANDE J, SWILLENS S et al Somatic mutations causing constitutive activity of the TSH receptor are the major cause of hyperfunctional thyroid adenomas : identification of additional mutations activating both the cAMP and inisitol-phosphate-Ca++ cascades. Mol Endocrinol 1995 ; 9 : 725-33.
18. PASCHKE R, TONZACCHERA M, VAN SANDE J, PARMA J, VASSART G. Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 1994 ; 79 : 1785-89.
19. PORCELLINI A, CIULLO I, LAVIOLA L et al. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 1994 ; 79 : 657-61.
20. RAO VR, COHEN GB, OPRIAN DD. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 1994 ; 367 : 639-42.
21. ROBBINS LS, NADEAU JH, JOHNSON KR et al. Pigmentation phenotypes of variant extension locus alleles results frompoint mutations that alter MSH receptor function. Cell 1993 ; 72 : 827-34.
22. ROBINSON PR, COHEN GB, ZHUKOVSKY EA, OPRIAN DD. Constitutively active mutants of rhodopsin. Neuron 1992 : 9 : 719-25.
23. SAMAMA P, COTECCHIA S, COSTA T, LEFKOWITZ RJ. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 1993 ; 268 : 4625-36.
24. SAMAMA P, PEI G, COSTA T, COTECCHIA S, LEFKOWITZ RJ. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. Mol Pharmacol 1994 ; 45 : 390-4.
25. SHENKER A, LAUE L, KOSUGI S et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993 ; 365 : 652-4.
26. STRADER CD, FONG TM, TOTA MR, Underwood D. Structure and function of G protei-coupled receptors. Annu Rev Biochem 1994 ; 63 : 101-32.
27. SUAREZ HG, DU VILLARD JA, CAILLOU B et al gsp mutations in human thyroid tumours. Oncogene 1991 ; 6 : 677-9.
28. THOMAS JS, LECLERE J, HARTEMANN P et al Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol Copenh 1982 ; 100 : 512-8
29. TIBERI M, CARON MG. High agonist-independent activity is a 2distinguishing feature of the dopamine DIB receptor subtype. J Biol Chem 1994 ; 269 : 27925-31.
30. VASSART G, DUMONT JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrinol Rev 1992 ; 13 : 596-611.
31. VASSART G, PARMA J, VAN SANDE J, DUMONT J. The thyrotropin receptor and the regulation of thyrocyte function and Growth : update 1994 ; Endocrinol Rev 1994 ; 3 : 77-80.